AllThingsLifeSciences/CleanTech: 2010 Investor Committee

Our invitation-only Investor Committee is a group of the most respected and well-regarded angel, VC, and corporate investors who are involved at all levels of the program's three primary components: Recruitment & Qualification, Coaching, and Connections.

Investor Committee List
Below are the 2010 Investor Committee members:

Jack Ahrens, TGap Ventures Stephen Kraus, Bessemer Venture Partners
Jahanara Ali, NYC Investment Fund Ron Lennox, CHL Medical Partners
Richard Anders, Mass Medical Angels (MA2) Reid Leonard, Merck & Co, Inc.
Ben Auspitz, Fidelity Biosciences Debra Liebel, Domain Associates
Elizabeth Bailey, Commons Capital Ellen Lubman, Bristol-Meyers Squibb
Kevin Bitterman, Polaris Venture Partners Michael Lytton, Biogen Idec
Dan Broderick, BioGenerator Carol Marino, Syngenta Venture Capital
Mike Bunker, Early Stage Partners Michael Melnick, CMEA Capital
James Burgum, Arthur Ventures Dan Meyer, Point Judith Capital
Christian Cortis, ATV Capital Pat Morand, SMLS Venture Fund
Ann Dewitt, Flagship Ventures Todd Morrill, Bio-Rad Laboratories
Cynthia Doerr, Essex Woodlands Health Ventures Dana Ono, VIMAC Ventures LLC
Ted Driscoll, Claremont Creek Ventures Catherine Oyler, Johnson & Johnson
Suzette Dutch, Triathlon Medical Ventures William Paiva, Sevin Rosen Funds
Stuart Eckmann, Life Science Angels Ann Partlow, Earthrise Capital
Teresa Esser, Capital Midwest Fund Pooja Pathak, Oxford Bioscience Partners
Pete Farner, TGap Ventures Susan Rohrer, Merck & Co, Inc.
Lauren Flanagan, Phenomenelle Angels Amita Shukla, New Enterprise Associates
Nancy Floyd, Nth Power Lauren Silverman, Novartis Venture Capital
Jennifer Friel, Goldstein Pfizer Inc Karen Spilizewski, RiverVest Venture Partners
Andrew Friendly, ATV Capital Richard Stuebi, Early Stage Partners
Jan Garfinkle, Arboretum Ventures Geeta Vemuri, BioVentures
Karen Hong, ProQuest Investments Tracy Warren, Battelle Ventures
Eva Jack, Medimmune Ventures Yael Weiss, Merck & Co, Inc.
Elaine Jones, Pfizer, Inc. Alex Zisson, Thomas McNerney & Partners
Kef Kasdin, Battelle Ventures


If you have any additional questions about the Investor Committee, please contact Joshua Henderson, Director of Programming at 202-242-8066 or by email at joshua@springboardenterprises.org.